Neurological Disorders Research

At Lilly, we want to continue developing and making medicines to meet the needs of people with neurological disorders, including neurodegenerative disorders. Neurological disorders are diseases of the central nervous system (CNS) and peripheral nervous system (PNS). They can affect the brain, spinal cord, nerves, and muscles throughout the body. Through clinical research we are finding out if new investigational medicines may help treat or slow down the development of many neurological conditions. These include:

  • Alzheimer’s disease (AD)
  • Amyotrophic lateral sclerosis (ALS)
  • Frontotemporal dementia (FTD) and other types of dementia and memory loss
  • Parkinson’s disease (PD)
  • Gaucher disease (GD)

By taking part in a clinical research study, you can help to make a difference. Click here to view clinical trials for neurological disorders.

A person playing chess sitting next to a person who is reading the newspaper. Both are smiling.

About Our Research

Lilly was founded in 1876 with the goal of making new high-quality medicines for the people that need them. The company’s aim is the same today! We work with people who take our medicines, healthcare workers who prescribe our medicines, our employees who make our medicines, and potential patients and caregivers in communities around the world to create the best possible research experience that we can.

Neurological Disorders Research Areas

There are many different types of neurological disorders. Neurodegenerative disorders are a category of neurological disorders. Neurodegenerative disorders can cause problems with memory, thinking, movement, coordination, along with other symptoms. Often neurodegenerative disorders are progressive, which means they get worse over time.
With clinical research studies, we can get more information about how neurological disorders start, get worse or improve. This helps us find ways to potentially prevent, better manage, and treat these conditions.
Click on the conditions below to learn more about the neurological disorders we are researching now. You can also view neurological disorders clinical trials or to learn more about Alzheimer’s disease and research in this area, visit our page about Alzheimer’s Disease.

Graphic of 3 puzzle pieces.

Lilly Trial Connect

Answer a few questions using Lilly Trial Connect to find which Lilly trials may be the best fit for you or your loved one.

Answer a few questions using Lilly Trial Connect to find which Lilly trials may be the best fit for you or your loved one.

Find a Trial

Conditions: Alzheimer Disease
Drugs: Mevidalen
Age
50 - 80 years
Phase
II
Conditions: Alzheimer's disease
Drugs: donanemab
Age
60 - 85 years
Phase
III
Conditions: Alzheimer's Disease
Drugs: LY3954068, Flortaucipir F18
Age
50 - 85 years
Phase
I
Conditions: Gaucher Disease, Type 1
Trial Name
PROCEED
Drugs: LY3884961
Age
18 - 65 years
Phase
II

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.

Not the right fit? Sign up to receive Lilly Trial Alerts to find out about new trials.

Learning Center

Two adults working together on a puzzle book and having fun. They are sitting outside.

Test Your Knowledge

Test your knowledge to see how much you know about clinical trials and neurological disorders research. Answer the following 10 questions to enhance your knowledge, or you might find out you are already an expert! 

Explore Research Areas

Lilly is committed to discovering and developing new medicines for people living with neurological disorders. Neurological disorders can include Alzheimer’s disease and neurological disorders caused by genetic mutations or changes.